CN102093340B - 2-甲基吲唑衍生物的制备及用途 - Google Patents
2-甲基吲唑衍生物的制备及用途 Download PDFInfo
- Publication number
- CN102093340B CN102093340B CN 201010579040 CN201010579040A CN102093340B CN 102093340 B CN102093340 B CN 102093340B CN 201010579040 CN201010579040 CN 201010579040 CN 201010579040 A CN201010579040 A CN 201010579040A CN 102093340 B CN102093340 B CN 102093340B
- Authority
- CN
- China
- Prior art keywords
- methyl
- indazole
- pyrimidine
- diamines
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 C[n]1nc(cc(cc2)N(*)c3ccnc(N*)n3)c2c1 Chemical compound C[n]1nc(cc(cc2)N(*)c3ccnc(N*)n3)c2c1 0.000 description 1
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010579040 CN102093340B (zh) | 2010-12-09 | 2010-12-09 | 2-甲基吲唑衍生物的制备及用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010579040 CN102093340B (zh) | 2010-12-09 | 2010-12-09 | 2-甲基吲唑衍生物的制备及用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102093340A CN102093340A (zh) | 2011-06-15 |
CN102093340B true CN102093340B (zh) | 2013-07-17 |
Family
ID=44126629
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201010579040 Expired - Fee Related CN102093340B (zh) | 2010-12-09 | 2010-12-09 | 2-甲基吲唑衍生物的制备及用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102093340B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1549813A (zh) * | 2000-12-21 | 2004-11-24 | 作为血管生成调节剂的嘧啶胺 |
-
2010
- 2010-12-09 CN CN 201010579040 patent/CN102093340B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1549813A (zh) * | 2000-12-21 | 2004-11-24 | 作为血管生成调节剂的嘧啶胺 |
Non-Patent Citations (2)
Title |
---|
Discovery of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor;Philip A. Harris, et.al.;《J. Med. Chem.》;20080712;第51卷(第15期);第4632–4640页 * |
Philip A. Harris, et.al..Discovery of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor.《J. Med. Chem.》.2008,第51卷(第15期),第4632–4640页. |
Also Published As
Publication number | Publication date |
---|---|
CN102093340A (zh) | 2011-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2015303641B2 (en) | 2-(2,4,5-substituted aniline) pyrimidine derivative, pharmaceutical composition and use thereof | |
CN103003250B (zh) | 作为激酶p70s6k抑制剂的二环氮杂环甲酰胺 | |
CN105985342B (zh) | 作为egfr抑制剂的嘧啶并嘧啶二酮衍生物及其应用 | |
CN105646454B (zh) | 含异羟肟酸片段的2-芳胺基嘧啶类衍生物及制备和应用 | |
CN107245075B (zh) | 2,4,6-三取代吡啶并[3,4-d]嘧啶类化合物及其盐和应用 | |
CN107827875B (zh) | 一种苯并咪唑类衍生物作为周期蛋白依赖性激酶4/6抑制剂的应用 | |
CN102060848B (zh) | 芳香胺取代的嘧啶衍生物的制备及用途 | |
CN107383016A (zh) | 含杂芳基酰胺结构的吡咯并嘧啶化合物的制备及应用 | |
CN105153026B (zh) | 含联芳基酰胺结构的索拉非尼衍生物及其制备方法和应用 | |
CN102093339B (zh) | 一类嘧啶衍生物的制备及用途 | |
CN101500562B (zh) | 噻吩并[3,2-c]吡啶-7-羧酸衍生物 | |
CN110028444B (zh) | 1-芳基-3-[4-(吡啶-2-基甲氧基)苯基]脲类化合物及应用 | |
CN102321074B (zh) | 吲哚环取代的吡唑酰肼类衍生物及其制备方法和应用 | |
CN102531949A (zh) | 一种取代苯甲酰胺类化合物及其制备方法和用途 | |
CN102093340B (zh) | 2-甲基吲唑衍生物的制备及用途 | |
CN102372675B (zh) | 6-氯-4-碘吲唑及其制备方法与应用 | |
CN105461708A (zh) | 喹唑啉类酪氨酸激酶抑制剂及其制备和应用 | |
TWI781497B (zh) | 氰基取代吡啶及氰基取代嘧啶類化合物、製備方法及其應用 | |
CN111362924B (zh) | 氘代的嘧啶衍生物及其用途 | |
CN110003177B (zh) | 含有脲基的苯并咪唑类化合物及应用 | |
CN103819467B (zh) | 喹唑啉衍生物的制备方法及其用途 | |
RU2570907C2 (ru) | Производные 3-ациламинопиридин-2(1h)-она, применимые как ингибиторы серин-треониновой протеинкиназы gsk3b в качестве лекарственных препаратов для лечения диабета ii типа. | |
CN109438279B (zh) | 一种克服egfr耐药突变的小分子化合物及其制备方法和用途 | |
CN107513040A (zh) | 取代苯并嘧啶类化合物的制备及分子靶向肿瘤治疗药物的应用 | |
CN103509024B (zh) | 嘧啶并苯并氮杂卓类化合物及其作为抗肿瘤药物的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 300193 Anshan West Road, Nankai District, Nankai District, Tianjin Patentee after: Tianjin Institute of Pharmaceutical Research Co.,Ltd. Address before: 300193 Anshan West Road, Nankai District, Nankai District, Tianjin Patentee before: Tianjin Institute of Pharmaceutical Research |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190225 Address after: 300301 No. 308 Huiren Road, Binhai Science Park, Tianjin Binhai High-tech Zone Patentee after: NEW DRUGS EVALUATE Co.,Ltd. TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH Address before: 300193 Anshan West Road, Nankai District, Nankai District, Tianjin Patentee before: Tianjin Institute of Pharmaceutical Research Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130717 Termination date: 20211209 |